Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 41 Triple Negative Breast Neoplasms 3 Carcinoma, Intraductal, Noninfiltrating 3 Unilateral Breast Neoplasms 1 Recurrence 1 Pain 1 Neoplasms 1 Lymphedema 1 Li-Fraumeni Syndrome 1 Inflammation 1 Hamartoma Syndrome, Multiple 1 Cystic Fibrosis 1 Carcinoma, Ductal, Breast 1 Breast Carcinoma In Situ 1 Breast Cancer Invasive 1 Breast Cancer Female 1

Interventions

pyrotinib 2 Surgical Procedures, Operative 2 pertuzumab 1 Trastuzumab 1 Neoadjuvant Therapy 1 Mastectomy 1 Leuprolide 1 Goserelin 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Breast Cancer Invasive × Mastectomy × Clear all

NCT03627988 2026-05-22

MARTA

Institut Claudius Regaud

Phase 2 Completed

Breast Cancer Invasive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡